Cleared Traditional

K960771 - SLAV AND SLAV-ONE INJECTION PORT CONNECTOR SYSTEM

K960771 is an FDA 510(k) clearance for SLAV AND SLAV-ONE INJECTION PORT CONNEC..., manufactured by Rymed Technologies, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 288-day FDA review.

K960771 · Rymed Technologies, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1996
Decision
288d
Days
Class 2
Risk

K960771 is an FDA 510(k) clearance for the SLAV AND SLAV-ONE INJECTION PORT CONNECTOR SYSTEM. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Rymed Technologies, Inc. (Woodward, US). The FDA issued a Cleared decision on December 10, 1996 after a review of 288 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Rymed Technologies, Inc. devices

FDA 510(k) Submission Details - K960771

510(k) Number K960771 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 1996
Decision Date December 10, 1996
Days to Decision 288 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 129d · This submission: 288d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 647
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K960771.
POLYFIN WITH WINGS INFUSION SETS, MODELS 306, 307, 333
K964455 · Medtronic Minimed · Jan 1997
POLYFIN QR WITH WINGS INFUSION SETS, MODELS 365, 366, AND 367
K964456 · Medtronic Minimed · Jan 1997
MODEL D-290P ADMINISTRATION SET
K964384 · Patient Solutions, Inc. · Jan 1997
INTERLINK ADAPTER FOR CONVENTIONAL Y-SITE
K962893 · Baxter Healthcare Corp · Oct 1996
DELTEC SUBCUTANEOUS INFUSION SET
K963009 · Sims Deltec, Inc. · Oct 1996
SAFE MATE I.V. EXTENSION SETS
K962801 · Biological & Environmental Control Laboratories · Aug 1996